In October, Indian authorities put a halt to the production of four cough syrups after the World Health Organization issued a warning against the drugs for being “potentially linked with acute kidney injuries and 66 deaths among children” in Gambia. Later, India concluded that the drugs sent to Gambia were safe and complied with Indian standards.